U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C35H52O4
Molecular Weight 536.785
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 4
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of HYPERFORIN

SMILES

CC(C)C(=O)[C@]12C(=O)[C@](CC=C(C)C)(C[C@H](CC=C(C)C)[C@@]1(C)CCC=C(C)C)C(=O)C(CC=C(C)C)=C2O

InChI

InChIKey=IWBJJCOKGLUQIZ-HQKKAZOISA-N
InChI=1S/C35H52O4/c1-22(2)13-12-19-33(11)27(16-14-23(3)4)21-34(20-18-25(7)8)30(37)28(17-15-24(5)6)31(38)35(33,32(34)39)29(36)26(9)10/h13-15,18,26-27,38H,12,16-17,19-21H2,1-11H3/t27-,33+,34+,35-/m0/s1

HIDE SMILES / InChI

Molecular Formula C35H52O4
Molecular Weight 536.785
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 4 / 4
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

PubMed

PubMed

TitleDatePubMed
Improved assays for xenosensor activation based on reverse transfection.
2015-10
Synthesis of novel vitamin K2 analogues with modification at the ω-terminal position and their biological evaluation as potent steroid and xenobiotic receptor (SXR) agonists.
2011-06-23
Enhanced steatosis by nuclear receptor ligands: a study in cultured human hepatocytes and hepatoma cells with a characterized nuclear receptor expression profile.
2010-03-30
A prolonged protein kinase C-mediated, opioid-related antinociceptive effect of st John's Wort in mice.
2010-02
Release of acetylcholinesterase (AChE) from beta-amyloid plaques assemblies improves the spatial memory impairments in APP-transgenic mice.
2008-09-25
HepaRG cells as an in vitro model for evaluation of cytochrome P450 induction in humans.
2008-01
Hyperforin--a key constituent of St. John's wort specifically activates TRPC6 channels.
2007-12
MDR- and CYP3A4-mediated drug-herbal interactions.
2006-03-27
Potential for interaction of kava and St. John's wort with drugs.
2005-08-22
No relevant interaction with alprazolam, caffeine, tolbutamide, and digoxin by treatment with a low-hyperforin St John's wort extract.
2005-04
Possible involvement of pregnane X receptor-enhanced CYP24 expression in drug-induced osteomalacia.
2005-01
Hyperforin, the active component of St. John's wort, induces IL-8 expression in human intestinal epithelial cells via a MAPK-dependent, NF-kappaB-independent pathway.
2004-11
In vitro interaction of the HIV protease inhibitor ritonavir with herbal constituents: changes in P-gp and CYP3A4 activity.
2004-07-22
Induction and inhibition of cytochromes P450 by the St. John's wort constituent hyperforin in human hepatocyte cultures.
2004-05
Proteome analysis reveals a distinct molecular profile of cellular stress following incubation of DDT1-MF2 smooth muscle cells in the presence of a high concentration of hyperforin.
2004-04
Induction of human CYP2C9 by rifampicin, hyperforin, and phenobarbital is mediated by the pregnane X receptor.
2004-02
St. John's wort extracts and some of their constituents potently inhibit ultimate carcinogen formation from benzo[a]pyrene-7,8-dihydrodiol by human CYP1A1.
2003-11-15
St John's wort, a herbal antidepressant, activates the steroid X receptor.
2000-09
St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor.
2000-06-20
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 19:55:18 GMT 2025
Edited
by admin
on Mon Mar 31 19:55:18 GMT 2025
Record UNII
RM741E34FP
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
(+)-HYPERFORIN
Preferred Name English
HYPERFORIN
HSDB   MI   WHO-DD  
Common Name English
HYPERFORIN (CONSTITUENT OF ST. JOHN'S WORT) [DSC]
Common Name English
Hyperforin [WHO-DD]
Common Name English
BICYCLO(3.3.1)NON-3-ENE-2,9-DIONE, 4-HYDROXY-6-METHYL-1,3,7-TRIS(3-METHYL-2-BUTEN-1-YL)-5-(2-METHYL-1-OXOPROPYL)-6-(4-METHYL-3-PENTEN-1-YL)-, (1R,5S,6R,7S)-
Systematic Name English
HYPERFORIN [HSDB]
Common Name English
HYPERFORIN [MI]
Common Name English
Classification Tree Code System Code
DSLD 1122 (Number of products:1)
Created by admin on Mon Mar 31 19:55:18 GMT 2025 , Edited by admin on Mon Mar 31 19:55:18 GMT 2025
Code System Code Type Description
CHEBI
5834
Created by admin on Mon Mar 31 19:55:18 GMT 2025 , Edited by admin on Mon Mar 31 19:55:18 GMT 2025
PRIMARY
CAS
11079-53-1
Created by admin on Mon Mar 31 19:55:18 GMT 2025 , Edited by admin on Mon Mar 31 19:55:18 GMT 2025
PRIMARY
MERCK INDEX
m6171
Created by admin on Mon Mar 31 19:55:18 GMT 2025 , Edited by admin on Mon Mar 31 19:55:18 GMT 2025
PRIMARY Merck Index
MESH
C001654
Created by admin on Mon Mar 31 19:55:18 GMT 2025 , Edited by admin on Mon Mar 31 19:55:18 GMT 2025
PRIMARY
HSDB
7646
Created by admin on Mon Mar 31 19:55:18 GMT 2025 , Edited by admin on Mon Mar 31 19:55:18 GMT 2025
PRIMARY
DRUG BANK
DB01892
Created by admin on Mon Mar 31 19:55:18 GMT 2025 , Edited by admin on Mon Mar 31 19:55:18 GMT 2025
PRIMARY
EPA CompTox
DTXSID90891409
Created by admin on Mon Mar 31 19:55:18 GMT 2025 , Edited by admin on Mon Mar 31 19:55:18 GMT 2025
PRIMARY
EVMPD
SUB183753
Created by admin on Mon Mar 31 19:55:18 GMT 2025 , Edited by admin on Mon Mar 31 19:55:18 GMT 2025
PRIMARY
SMS_ID
100000169967
Created by admin on Mon Mar 31 19:55:18 GMT 2025 , Edited by admin on Mon Mar 31 19:55:18 GMT 2025
PRIMARY
FDA UNII
RM741E34FP
Created by admin on Mon Mar 31 19:55:18 GMT 2025 , Edited by admin on Mon Mar 31 19:55:18 GMT 2025
PRIMARY
WIKIPEDIA
HYPERFORIN
Created by admin on Mon Mar 31 19:55:18 GMT 2025 , Edited by admin on Mon Mar 31 19:55:18 GMT 2025
PRIMARY
Related Record Type Details
TRANSPORTER -> INHIBITOR